+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Neurostimulation Devices Market 2018-2022 - Product Image

Global Neurostimulation Devices Market 2018-2022

  • ID: 4744626
  • Report
  • December 2018
  • Region: Global
  • 127 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott
  • Boston Scientific
  • LivaNova
  • Medtronic
  • Nevro
  • MORE
The prevalence of several neurological disorder is increasing across the world. The probability of diseases such as AD, PD, UI, fecal incontinence, epilepsy, dementia, and movement disorders increases significantly with age. Hence the prevalence of neurological disorders increases due to the growth of the aging population. other risk factors associated with neurological disorders such as high blood pressures (BP), obesity and the consumption of alcohol and tobacco are also increasing. Therefore, the rising prevalence of neurological disorders drives the growth of the market. The analysts have predicted that the neurostimulation devices market will register a CAGR of almost 11% by 2022.

Market Overview

Rising prevalence of neurological disorders

The increasing prevalence of several neurological disorders is increasingly, globally. Therefore, the aging population will positively affect the prevalence of neurological disorders.

High cost of neurostimulation devices and procedures

The high cost of neurostimulation devices limits their adoption in several developing countries. The availability of information about the cost of neurostimulation devices is limited. Therefore, gathering data about the high cost of neurostimulation devices is s complex task.

For the detailed list of factors that will drive and challenge the growth of the neurostimulation devices market during the 2018-2022, view this report.

Competitive Landscape

The neurostimulation devices market is concentrated. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.’
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott
  • Boston Scientific
  • LivaNova
  • Medtronic
  • Nevro
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 05: MARKET SIZING
  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 07: MARKET SEGMENTATION BY PRODUCT
  • Overview
  • Comparison by product
  • Implantable neurostimulation devices
  • External neurostimulation devices
  • Market opportunity by product
PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE
  • Geographical segmentation
  • Regional comparison
  • Americas
  • EMEA
  • APAC
  • Market opportunity
PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 12: MARKET TRENDS
  • Expanding indications of neurostimulation devices
  • Increasing number of initiatives that support research related to
  • neurostimulation technology
PART 13: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 14: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • Boston Scientific
  • LivaNova
  • Medtronic
  • Nevro
PART 15: APPENDIX
  • List of abbreviations
List of Exhibits
Exhibit 01: Global medical devices market
Exhibit 02: Global medical devices market: Segments
Exhibit 03: Market characteristics
Exhibit 04: Global neurostimulation devices market: Segments
Exhibit 05: Market definition: Inclusions and exclusions checklist
Exhibit 06: Global neurostimulation devices market: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global neurostimulation devices market: Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global neurostimulation devices market: Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition: Five forces 2017
Exhibit 18: Segmentation by product: Market share 2017-2022 (%)
Exhibit 19: Comparison by product
Exhibit 20: Implantable neurostimulation devices: Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Implantable neurostimulation devices: Year-over-year growth 2018-2022 (%)
Exhibit 22: External neurostimulation devices: Market size and forecast 2017-2022 ($ mn)
Exhibit 23: External neurostimulation devices: Year-over-year growth 2018-2022 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Segmentation by geography: Market share 2017-2022 (%)
Exhibit 27: Regional comparison
Exhibit 28: Americas: Market size and forecast 2017-2022 ($ mn)
Exhibit 29: Americas: Year-over-year growth 2018-2022 (%)
Exhibit 30: Top three countries in Americas
Exhibit 31: EMEA: Market size and forecast 2017-2022 ($ mn)
Exhibit 32: EMEA: Year-over-year growth 2018-2022 (%)
Exhibit 33: Top three countries in EMEA
Exhibit 34: APAC: Market size and forecast 2017-2022 ($ mn)
Exhibit 35: APAC: Year-over-year growth 2018-2022 (%)
Exhibit 36: Top three countries in APAC
Exhibit 37: Market opportunity
Exhibit 38: Vendor landscape
Exhibit 39: Landscape disruption
Exhibit 40: Vendors covered
Exhibit 41: Vendor classification
Exhibit 42: Market positioning of vendors
Exhibit 43: Abbott: Overview
Exhibit 44: Abbott: Business segments
Exhibit 45: Abbott: Organizational developments
Exhibit 46: Abbott: Geographic focus
Exhibit 47: Abbott: Segment focus
Exhibit 48: Abbott: Key offerings
Exhibit 49: Abbott: Key customers
Exhibit 50: Boston Scientific: Overview
Exhibit 51: Boston Scientific: Business segments
Exhibit 52: Boston Scientific: Organizational developments
Exhibit 53: Boston Scientific: Geographic focus
Exhibit 54: Boston Scientific: Segment focus
Exhibit 55: Boston Scientific: Key offerings
Exhibit 56: Boston Scientific: Key customers
Exhibit 57: LivaNova: Overview
Exhibit 58: LivaNova: Business segments
Exhibit 59: LivaNova: Organizational developments
Exhibit 60: LivaNova: Geographic focus
Exhibit 61: LivaNova: Segment focus
Exhibit 62: LivaNova: Key offerings
Exhibit 63: LivaNova: Key customers
Exhibit 64: Medtronic: Overview
Exhibit 65: Medtronic: Business segments
Exhibit 66: Medtronic: Organizational developments
Exhibit 67: Medtronic: Geographic focus
Exhibit 68: Medtronic: Segment focus
Exhibit 69: Medtronic: Key offerings
Exhibit 70: Medtronic: Key customers
Exhibit 71: Nevro: Overview
Exhibit 72: Nevro: Business segments
Exhibit 73: Nevro: Organizational developments
Exhibit 74: Nevro: Geographic focus
Exhibit 75: Nevro: Key offerings
Exhibit 76: Nevro: Key customers
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Abbott
  • Boston Scientific
  • LivaNova
  • Medtronic
  • Nevro
  • MORE
Global Neurostimulation Devices Market 2018-2022

The analyst recognizes the following companies as the key players in the global neurostimulation devices market: Abbott, Boston Scientific, LivaNova, Medtronic, Nevro.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the expanding indications of neurostimulation devices.”

According to the report, one of the major drivers for this market is the rising prevalence of neurological disorders drives the growth pf the market.

Further, the report states that one of the major factors hindering the growth of this market is the high cost of neurostimulation devices and procedures.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Abbott
  • Boston Scientific
  • LivaNova
  • Medtronic
  • Nevro
Note: Product cover images may vary from those shown
Adroll
adroll